High Dose Radiotherapy for Palliation (Hi-D)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBritish Columbia Cancer Agency
About this trial
The goal of this clinical trial is to evaluate the feasibility of single-blind randomization between two palliative regimens - standard 24 Gray in 3 fractions vs a high-dose (Hi-D) 27 Gray in 3 fractions with dose escalation within the tumor in participants with bulky metastatic cancer.
The main question
Eligibility criteria
Qualifiers
Age 18 or older.
Able to provide informed consent
Patient has histologically confirmed solid tumour malignancy
ECOG performance status 0 - 2
Disqualifiers
- Hematologic malignancy.
Disease limited to intracranial sites
Serious medical co-morbidities precluding radiotherapy
Bone metastases with no soft tissue component
Trial design
Treatments tested in this trial
- Palliative Radiotherapy
- Palliative Radiotherapy
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov